104 related articles for article (PubMed ID: 1479714)
1. [Effects of intravenously infused magnesium on renal calcium metabolism and plasma parathyroid hormone in patients with essential hypertension].
Satoh N; Kikuchi K; Komura H; Suzuki S; Ohtomo T; Takada T; Nanba M; Marusaki S; Iimura O
Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):743-51. PubMed ID: 1479714
[TBL] [Abstract][Full Text] [Related]
2. [The effects of intravenous infused magnesium on hemodynamics and renal water-sodium metabolism in patients with essential hypertension].
Ohtomo T; Kikuchi K; Komura H; Nozawa A; Hasegawa T; Suzuki S; Satoh N; Takada T; Iimura O
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):977-84. PubMed ID: 2585837
[TBL] [Abstract][Full Text] [Related]
3. [The role of the Na, K-ATPase inhibitor in renal sodium handling in patients with essential hypertension].
Komura H; Kikuchi K; Nozawa A; Hasegawa T; Suzuki S; Yamamoto M; Satoh N; Ohtomo T; Takada T; Iimura O
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):775-81. PubMed ID: 2555614
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertension.
Kikuchi K; Miyama A; Nakao T; Takigami Y; Kondo A; Mito T; Ura N; Tsuzuki M; Iimura O
Jpn Circ J; 1982 May; 46(5):486-93. PubMed ID: 7043016
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiological role of renal dopaminergic activity in patients with essential hypertension.
Iimura O; Yamaji I; Kikuchi K; Shibata S; Nishimura M; Nozawa A; Aoki K; Hasegawa T; Kobayakawa H; Komura H
Jpn Circ J; 1987 Oct; 51(10):1232-40. PubMed ID: 3323560
[TBL] [Abstract][Full Text] [Related]
6. [The role of the renal dopaminergic and the prostaglandin systems in renal uric acid metabolism in patients with essential hypertension].
Satoh N; Kikuchi K; Hasegawa T; Komura H; Suzuki S; Ohtomo T; Takada T; Nanba M; Marusaki S; Iimura O
Nihon Naibunpi Gakkai Zasshi; 1991 Nov; 67(11):1271-81. PubMed ID: 1761141
[TBL] [Abstract][Full Text] [Related]
7. Effects of head-out water immersion on the urinary excretion of phosphate, calcium and magnesium in the awake dog.
Ayus JC; Frommer JP; Eknoyan G; Divine G; Suki WN
Miner Electrolyte Metab; 1984; 10(1):67-72. PubMed ID: 6738466
[TBL] [Abstract][Full Text] [Related]
8. Relationships between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population.
Hvarfner A; Bergström R; Mörlin C; Wide L; Ljunghall S
J Hypertens; 1987 Aug; 5(4):451-6. PubMed ID: 3668247
[TBL] [Abstract][Full Text] [Related]
9. Urinary calcium excretion in essential hypertension.
Young EW; Morris CD; McCarron DA
J Lab Clin Med; 1992 Oct; 120(4):624-32. PubMed ID: 1402338
[TBL] [Abstract][Full Text] [Related]
10. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
[TBL] [Abstract][Full Text] [Related]
11. [Renal sodium handling and renal dopaminergic activity in overweight normotensive subjects].
Kudoh C; Kikuchi K; Yamaji I; Kobayakawa H; Yamamoto M; Shimazaki M; Sakamoto T; Wada A; Sawai N; Mukai H
Nihon Naibunpi Gakkai Zasshi; 1991 Jun; 67(6):682-91. PubMed ID: 1889510
[TBL] [Abstract][Full Text] [Related]
12. The pathophysiological role of water-sodium balance and renal dopaminergic activity in overweight patients with essential hypertension.
Kikuchi K; Iimura O; Yamaji I; Shibata S; Nishimura M; Aoki K; Nozawa A; Hasegawa T; Honma C; Kobayakawa H
J Clin Hypertens; 1987 Mar; 3(1):3-11. PubMed ID: 3572460
[TBL] [Abstract][Full Text] [Related]
13. Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency.
Reichel H; Deibert B; Geberth S; Schmidt-Gayk H; Ritz E
Nephrol Dial Transplant; 1992; 7(1):8-15. PubMed ID: 1316586
[TBL] [Abstract][Full Text] [Related]
14. Regulation of parathyroid hormone and vitamin D in essential hypertension.
Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
[TBL] [Abstract][Full Text] [Related]
15. [The role of hyperinsulinemia on the renal mechanism of hyperuricemia in overweight patients with essential hypertension].
Takada T; Kikuchi K; Hasegawa T; Komura H; Suzuki S; Satoh N; Ohotomo T; Nanba M; Marusaki S; Iimura O
Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):861-70. PubMed ID: 1813326
[TBL] [Abstract][Full Text] [Related]
16. The role of renal kallikrein-kinin system and prostaglandins in diuresis and natriuresis following saline infusion in normotensives and essential hypertensives.
Nishimiya T; Shimamoto K; Tanaka S; Ura N; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Masuca A; Iimura O
Adv Exp Med Biol; 1986; 198 Pt B():337-42. PubMed ID: 3643730
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous calcium infusion on indices of activity of the parathyroid glands and on urinary calcium and sodium excretion in normotensive and hypertensive subjects.
Papagalanis N; Kourti A; Tolis A; Skopelitis P; Karabatsos A; Kostoyanni G; Gennadiou M; Elisaf M; Mountokalakis T
Am J Hypertens; 1993 Jan; 6(1):59-65. PubMed ID: 8427663
[TBL] [Abstract][Full Text] [Related]
18. Calcemic response to parathyroid hormone in spontaneously hypertensive rats: role of calcitriol.
Hsu CH; Patel S; Young EW
J Lab Clin Med; 1987 Dec; 110(6):682-9. PubMed ID: 3681111
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of hypercalciuria in spontaneously hypertensive rats.
Hsu CH; Chen PS; Smith DE; Yang CS
Miner Electrolyte Metab; 1986; 12(2):130-41. PubMed ID: 3960017
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
